Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center
Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center. // American Journal of Preventive Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S2666667726003089?dgcid=rss_sd_all
Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center. American Journal of Preventive Cardiology. https://www.sciencedirect.com/science/article/pii/S2666667726003089?dgcid=rss_sd_all
“Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center.” American Journal of Preventive Cardiology.
@article{article99642,
title = {Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center},
journal = {American Journal of Preventive Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S2666667726003089?dgcid=rss_sd_all}
}